Correlation Between Salarius Pharmaceuticals and Artelo Biosciences

Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salarius Pharmaceuticals and Artelo Biosciences, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Artelo Biosciences.

Diversification Opportunities for Salarius Pharmaceuticals and Artelo Biosciences

0.0

Correlation Coefficient

Salarius Pharmaceuticals  Artelo Biosciences

Pay attention - limited upside

The 3 months correlation between Salarius and Artelo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and Artelo Biosciences

If you would invest  152.00  in Salarius Pharmaceuticals on December 30, 2024 and sell it today you would lose (66.00) from holding Salarius Pharmaceuticals or give up 43.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Salarius Pharmaceuticals  vs.  Artelo Biosciences

Salarius Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Salarius Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Salarius Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Artelo Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Artelo Biosciences is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Salarius Pharmaceuticals and Artelo Biosciences

The main advantage of trading using opposite Salarius Pharmaceuticals and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.

The idea behind Salarius Pharmaceuticals and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.